Toggle navigation
Home
Search
Services
Blog
Contact
About
Prioritize, Review Marketed Pediatric Drugs
Johnson, Keith
U.S. Pharmacopeia, Rockville, MD, United States
Search 174 grants from Keith Johnson
Search grants from U.S. Pharmacopeia
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Filtered: a story-driven digital learning platform for bioinformatics and infectious disease
The Reach and Effectiveness of Technology-Enhanced Diabetes Prevention Programs
National Children's Study Biomedical (Applied/Exploratory)
Quincy Community Coalition to Reduce Substance Abuse
Oklahoma Comprehesive Cancer Control, Cancer Registry, Brest and Cervical Cancer
Recently added grants:
A Coordinated Parent/Child Dyad Weight Loss Intervention: Dyad Plus
Reconstructing mechanisms of somatic variation in diverse cellular lineages
Physiological mechanisms of action relating to immediate and long-term therapeutic horseback riding intervention effects in a psychiatric population of youth with autism spectrum disorder
Molecular Pathogenesis of Fanconi Anemia
Human Platelet Defects in Transcription Factor RUNX1 Haplodeficiency
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research and Development Contracts (N01)
Project #
N01HD093305-000
Application #
6153548
Study Section
Project Start
1999-09-30
Project End
2004-09-29
Budget Start
1999-09-30
Budget End
2000-09-29
Support Year
Fiscal Year
1999
Total Cost
Indirect Cost
Institution
Name
U.S. Pharmacopeia
Department
Type
DUNS #
City
Rockville
State
MD
Country
United States
Zip Code
20852
Related projects
NIH 2000
N01 HD
Prioritize, Review Marketed Pediatric Drugs
Johnson, Keith / U.S. Pharmacopeia
$132,551
NIH 1999
N01 HD
Prioritize, Review Marketed Pediatric Drugs
Johnson, Keith / U.S. Pharmacopeia
Comments
Be the first to comment on Keith Johnson's grant